Related Experiment Video
Updated: Jan 17, 2026
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
Published on: April 8, 2016
Cross-Modality Learning for Predicting Immunohistochemistry Biomarkers from Hematoxylin and Eosin-Stained Whole Slide
Amit Das1, Naofumi Tomita2, Kyle J Syme3
1Department of Computer Science, Dartmouth College, Hanover, New Hampshire.
Insights
This study introduces HistoStainAlign, a deep learning tool predicting immunohistochemistry (IHC) patterns from H&E images, reducing costs and time for cancer diagnosis. The AI framework enhances pathology workflow efficiency by prioritizing cases needing IHC staining.
Area of Science:
- Computational pathology
- Artificial intelligence in histopathology
- Digital pathology
Background:
- Hematoxylin and eosin (H&E) staining is crucial for cancer diagnosis, but immunohistochemistry (IHC) provides specific protein insights.
- IHC staining is expensive, time-consuming, and requires specialized expertise, limiting its widespread application.
Purpose of the Study:
- To develop a novel deep learning framework, HistoStainAlign, capable of predicting IHC staining patterns directly from H&E whole slide images.
- To overcome the limitations of traditional IHC staining by offering a cost-effective and efficient computational alternative.
Main Methods:
- HistoStainAlign integrates paired H&E and IHC embeddings using a contrastive training strategy.
- The framework captures cross-modal features without requiring patch-level annotations or tissue registration.
- The model was validated on gastrointestinal and lung tissues for P53, PD-L1, and Ki-67 IHC stains.
Main Results:
- HistoStainAlign achieved weighted F1 scores of 0.735 for P53, 0.830 for PD-L1, and 0.723 for Ki-67.
- Embedding analyses confirmed the model's ability to capture meaningful cross-stain relationships.
- The contrastive learning approach demonstrated superior performance compared to a baseline model for stain pattern prediction.
Conclusions:
- HistoStainAlign shows significant potential as a computational prescreening tool in pathology.
- The framework can improve workflow efficiency by identifying cases that would benefit most from IHC staining.
- This approach offers a promising direction for enhancing diagnostic accuracy and treatment planning in oncology.
Abstract:
Hematoxylin and eosin (H&E) staining is a cornerstone of pathologic analysis, offering reliable visualization of cellular morphology and tissue architecture for cancer diagnosis, subtyping, and grading. Immunohistochemistry (IHC) staining provides insights by detecting specific proteins within tissues, enhancing diagnostic accuracy, and improving treatment planning. However, IHC staining is costly, time-consuming, and resource intensive, requiring specialized expertise. To address these limitations, this study proposes HistoStainAlign, a novel deep learning framework that predicts IHC staining patterns directly from H&E whole slide images. The framework integrates paired H&E and IHC embeddings through a contrastive training strategy, capturing complementary features across staining modalities without patch-level annotations or tissue registration. The model was evaluated on gastrointestinal and lung tissue whole slide images with three commonly used IHC stains: P53, programmed death ligand-1, and Ki-67. HistoStainAlign achieved weighted F1 scores of 0.735 (95% CI, 0.670-0.799), 0.830 (95% CI, 0.772-0.886), and 0.723 (95% CI, 0.607-0.836), respectively for these three IHC stains. Embedding analyses demonstrated the robustness of the contrastive alignment in capturing meaningful cross-stain relationships. Comparisons with a baseline model further highlight the advantage of incorporating contrastive learning for improved stain pattern prediction. This study demonstrates the potential of computational approaches to serve as a prescreening tool, helping prioritize cases for IHC staining and improving workflow efficiency.
